Teladoc Health: Just What The Doctor Ordered

Summary:

- Teladoc Health recently reported solid Q2 2018 operating results that were well-received by the market.

- This telehealth company has promising long-term business prospects and its backdrop seems to be improving by the day.

- I am long Teladoc Health and I plan to add to my position in the near future.

Teladoc Health ($TDOC) is shaking up an industry that needs disrupted. The company's telehealth platform and other related services are garnering a ton of buzz (and usage) in the healthcare industry and I believe that Teladoc is just getting started. The company's stock performance is telling the same story, as TDOC shares have outperformed the S&P 500 by a wide margin over the last year.

I posted "Teladoc Is Worth A Look" in early April 2018 and shares have already ticked higher (shares were in the lower $40 range) but, in my opinion, investors with a long-term perspective should seriously consider continuing to accumulate TDOC shares even in the $60 range.